Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ATAC-sequencing of genetically engineered intestinal organoid lines modeling colorectal cancer (CRC) progression

ABSTRACT: ATAC-sequencing of genetically engineered intestinal organoid lines modeling colorectal cancer (CRC) progression

PROVIDER: PRJNA1000916 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25474447_1.fastq.gz	Fastqsanger.gz
	SRR25474447_2.fastq.gz	Fastqsanger.gz
	SRR25474448_1.fastq.gz	Fastqsanger.gz
	SRR25474448_2.fastq.gz	Fastqsanger.gz
	SRR25474449_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-sequencing of genetically engineered intestinal organoid lines modeling colorectal cancer (CRC) progression

Project description:RNA-sequencing of genetically engineered intestinal organoid lines modeling colorectal cancer (CRC) progression

| PRJNA1000918 | ENA

RNA-sequencing of genetically engineered intestinal organoid lines modeling colorectal cancer (CRC) progression

Project description:To characterize the transcriptional changes acorss the CRC malignancy continum, wild type organoids (WT), ApcKO (A) and ApcKO::KrasG12D::Smad4KO::Trp53KO (AKSP) tumoroids were subjected to bulk RNA_seq. We then performed gene expression profiling analysis using data obtained from mRNA-seq of the indicated organoid lines.

2024-10-17 | GSE239754 | GEO

ATAC-sequencing of genetically engineered intestinal organoid lines modeling colorectal cancer (CRC) progression

Project description:To characterize changes in chromatin accessibility acorss the CRC malignancy continum, wild type organoids (WT), ApcKO (A) and ApcKO::KrasG12D::Smad4KO::Trp53KO (AKSP) tumoroids were subjected to bulk ATAC-seq. We then performed differential accessibility analysis using data obtained from ATAC-seq of the indicated organoid lines.

2024-10-17 | GSE239752 | GEO

Modeling melanoma resistance in a genetically engineered mouse model

Project description:Modeling melanoma resistance in a genetically engineered mouse model

| PRJNA650202 | ENA

Mapping prohormone processing by proteases in human enteroendocrine cells using genetically engineered organoid models

Project description:Mapping prohormone processing by proteases in human enteroendocrine cells using genetically engineered organoid models

| PRJNA876295 | ENA

RNA-seq of genetically engineered mouse microglia

Project description:RNA-seq of genetically engineered mouse microglia sorted into populations.

2022-04-06 | GSE196174 | GEO

RNA-seq of genetically engineered mouse microglia

Project description:RNA-seq of genetically engineered mouse microglia

| PRJNA803528 | ENA

TGFÎ² signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype [organoids]

Project description:The aim of this study was to determine the effects of TGFÎ² at the premalignant stage of CRC development. Organoid cultures were isolated from normal colon and from tubular adenomas. One normal colon culture was genetically engineered using the CRISPR-Cas9 system to carry the BRAFV600E mutation. Organoid cultures of three different tubular adenomas and two normal colon samples, and one BRAFV600E-mutant organoid culture received TGFÎ² or control treatment after which gene expression was analyzed by microarray (Affymetrix U133+ PM Genechip Array).

2016-06-01 | E-GEOD-79461 | biostudies-arrayexpress

Organoid modeling of the tumor immune microenvironment

Project description:Organoid modeling of the tumor immune microenvironment

| PRJNA436710 | ENA

GEMM CRC collection analysis

Project description:A collection of genetically engineered mouse models (GEMM) of colorectal cancer (CRC) were created, and primary tumors from these GEMMs were analyzed. Primary CRC tumors from these GEMMs were genotyped to confirm that they contain the core genetic lesions of interest, including APC, P53, KRAS, and BRAF. Primary tumors from GEMMs with combinations of lesions of interest were analyzed by whole genome expression, and their expression profiles were compared to determine how they segregate. Signatures were then generated from GEMM tumors of interest and compared to human clinical datasets with expression and outcome data. Primary tumors from CRC GEMMs with different combinations of mutant alleles of interested were generated and analyzed. Alleles include mutant forms of APC (A), P53 (P), KRAS (K) and BRAF (B).

2014-07-01 | E-GEOD-50794 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data